BAGUERA® C 10-YEAR CLINICAL FOLLOW-UP STUDY IN THE EUROPEAN SPINE JOURNAL.
After the 5-Year clinical results published in 2018, we are proud to announce that the European Spine Journal has just published the 10-Year results.
81 patients continued their follow up to 10-years and the results confirm the long-term performance and safety of the device. In a nutshell, at 10 years the range of motion is preserved in 86.6% of the patients, the upper adjacentdisc height is preserved with no degeneration, compared with the pre-operative height. There are no long-term device or surgery related complications and no progressive osteolysis is observed.
We look forward to seeing the 15-Year results!
SPINEART AND SANYOU MEDICAL ENTERED INTO AN EXCLUSIVE DISTRIBUTION AGREEMENT.
On April 1st, 2023, Spineart SA has entered into an exclusive distribution agreement with Sanyou Medical to sell Spineart technologies in China. Both companies will cooperate particularly in the field of motion preservation technology focusing on BAGUERA® C disc replacement. The partnership combines Spineart 15 years of experience in spinal arthroplasty with Sanyou’s expertise and reach in the clinical requirements of the Chinese spine market.
About Spineart
Spineart is a privately held medical device company focused on simplifying the surgical act by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams, and patients. Spineart markets a complete portfolio, in 60 markets, combining traceable barcoded sterile packed implants with compact instrument sets, thus proudly promoting greater safety, cost-efficiency, and compliance at the hospital.
About Sanyou Medical
Founded in 2005, Shanghai Sanyou Medical Co, Ltd. is a company dedicated to the R&D, manufacturing and sales of innovative and independent orthopedic products. The main products of Shanghai Sanyou are spinal and trauma implants. Shanghai Sanyou is one of the few companies with the ability to commercialize original innovations based on clinical requirements in the field of spinal implants in China.
FIRST SPINE SUMMIT OF THE YEAR!
25 surgeons from around the United States converged on Park City this past weekend for our Winter National Spine Summit.
The first day of the summit addressed cervical disorders (artificial disc, osteoporosis, Anterior Scoliosis correction). Lumbar disorders were primarily the topic of day two.
The robust discussions were led by our expert faculty, Dr. Bob Banco and Dr. Dimitriy Kondrashov.
Our participants came prepared and eager to engage with their peers. We’re so grateful for the knowledge they shared and enjoyed valuable time with all!
NEW SPINEART DEFORMITY SYSTEM PERLA® TL LC – FIRST WORLDWIDE SURGERIES
Spineart is proud to announce the first surgeries involving the PERLA® TL LC system, the new PERLA® TL add-on dedicated to the treatment of spine deformity.
PERLA® TL LC is the extension of the PERLA® TL Posterior Thoracolumbar Fixation System and includes:
- Brand new tower reducers with unilateral / bilateral clip-on versions, long run, powerful reduction and quick release for per-op flexibility
- Exclusive 25D semi-polyaxial screw for optimized control of the vertebral rotation
- Extensive range of implants including hooks, Z-rods and rod connectors
Dr. DECKEY, Orthopaedic Specialty Institute (Orange, CA, USA) declared that “The PERLA® TL LC system is a clear advance for Spineart in treating a wide range of spine deformity cases. The variety of screw insertion, rod reduction and in-situ bending instrument options provide the versatility I need for even my most complex cases. “
Dr. OBEID, University Hospital of Bordeaux (Bordeaux, FRANCE) reported that “PERLA® TL LC allows all strategies of correction for adolescent and adult. The tower reducers are easy to use, efficient and progressive, limiting the risk of screw pull-out. Short and long versions of instruments reduce efforts on surgeon’s shoulders.“
Dr. PEIRO, Sant Joan de Déu Barcelona Children’s Hospital (Barcelona, SPAIN) commented that “The range of instruments available allows the surgeon to perform any kind of correction maneuver. The new tower reducers combined with 25D screws are powerful tools to perform big corrections. PERLA® TL LC is a great system that makes complex spine deformity surgeries easier.“
Prof. STRUBE, German Center for Orthopedics (Eisenberg, GERMANY) said that “PERLA® TL LC is a solid and efficient deformity solution with lots of improvements. It is easy to handle and enables all parts of 3D-correction with the help of the fantastic 25D screw feature.“
PERLA® TL LC is under limited release.
PERLA® TL and PERLA® TL MIS systems for degenerative open and minimally invasive surgeries are respectively fully available since July 2021 and October 2022.
FIRST SPINEART ACADEMY OF 2023!
Spineart is delighted to have welcomed surgeons to this year’s first Academy, held at the Sharjah University in Dubai on February 2-3rd.
Participants from various parts of the Middle East and North Africa had the opportunity to enhance their knowledge of Minimally Invasive Surgery in both didactic and anatomical laboratory settings.
We would like to thank our Chairman and Faculties, Dr. Wael Chaaban, Pr. Gianluca Maestretti, Dr. Mohamed Awad and Dr. Wael Elkasem, for sharing their expertise, and all the participants for their great exchanges.
As part of Spineart’s on-going commitment to education, many specialized programs have been planned for 2023. Contact your Spineart representative for more information.
ENROLLMENT COMPLETION OF THE BAGUERA® L STUDY
Spineart is delighted to announce that 73 patients have been included, thus completing the enrollment of the BAGUERA® L study!
BAGUERA® L is a prosthesis intended as a replacement for a lumbar intervertebral disc, in patients with symptomatic lumbar disc disease. The patients were treated with BAGUERA® L from 2013 to 2018 in France and Germany. This study is monitoring the long-term safety and performance of BAGUERA® L.
We look forward to the results of this study and would like to thank Dr. Pedram from the Centre Aquitain du dos (France), Dr. Janata from the Grenzland MVZ (Germany), as well as their clinical teams, for their involvement and dedication to this clinical study and for reaching this milestone!
Here are a few words from them on the BAGUERA® L:
“BAGUERA® L is a reliable implant for total disc replacement with very good long-term results. The instruments are user friendly and allow exact placement of the implant at the disc space.” commented Dr. Janata.
“BAGUERA® L combines ease of installation, MRI compatibility and the ability to choose a mobile or fixed core according to anatomical conditions.” said Dr. Pedram.